Gabapentin and opioid craving.
Tay
Kwang Hui
KH
D000082:Acetaminophen / Q000627:therapeutic use; D000588:Amines / Q000008:administration & dosage*; D000700:Analgesics / Q000008:administration & dosage; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use; D018771:Arthralgia / Q000188:drug therapy / Q000209:etiology; D002047:Buprenorphine / Q000008:administration & dosage; D003061:Codeine / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage*; D004338:Drug Combinations; D000077206:Gabapentin; D006801:Humans; D007718:Knee Injuries / Q000150:complications / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D010098:Oxycodone / Q000627:therapeutic use; D015819:Substance Abuse, Intravenous / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D014147:Tramadol / Q000008:administration & dosage; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage*
D000588:Amines; D000700:Analgesics; D000701:Analgesics, Opioid; D003509:Cyclohexanecarboxylic Acids; D004338:Drug Combinations; C526278:acetaminophen, codeine drug combination; D000082:Acetaminophen; D014147:Tramadol; D002047:Buprenorphine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D010098:Oxycodone; D003061:Codeine